The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global Hospital-acquired infections (HAIs) Control Market Research Report 2025
Synopsis
The global Hospital-acquired infections (HAIs) Control market was valued at US$ 5702.2 million in 2023 and is anticipated to reach US$ 6985.5 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hospital-acquired infections (HAIs) Control, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital-acquired infections (HAIs) Control.
Report Scope
The Hospital-acquired infections (HAIs) Control market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital-acquired infections (HAIs) Control market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital-acquired infections (HAIs) Control companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
STERIS Corporation
Advanced Sterilization Products Division
Hoffmann-La Roche
Pfizer
Becton Dickinson
Segment by Type
Diagnostic techniques
Dleaning and sterilization
Treatment
Segment by Application
General Hospital
Infectious Disease Hospital
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital-acquired infections (HAIs) Control companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
The global Hospital-acquired infections (HAIs) Control market was valued at US$ 5702.2 million in 2023 and is anticipated to reach US$ 6985.5 million by 2030, witnessing a CAGR of 2.9% during the forecast period 2024-2030.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
This report aims to provide a comprehensive presentation of the global market for Hospital-acquired infections (HAIs) Control, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Hospital-acquired infections (HAIs) Control.
Report Scope
The Hospital-acquired infections (HAIs) Control market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Hospital-acquired infections (HAIs) Control market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Hospital-acquired infections (HAIs) Control companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
STERIS Corporation
Advanced Sterilization Products Division
Hoffmann-La Roche
Pfizer
Becton Dickinson
Segment by Type
Diagnostic techniques
Dleaning and sterilization
Treatment
Segment by Application
General Hospital
Infectious Disease Hospital
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Hospital-acquired infections (HAIs) Control companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Hospital-acquired infections (HAIs) Control Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Diagnostic techniques
1.2.3 Dleaning and sterilization
1.2.4 Treatment
1.3 Market by Application
1.3.1 Global Hospital-acquired infections (HAIs) Control Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 General Hospital
1.3.3 Infectious Disease Hospital
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Hospital-acquired infections (HAIs) Control Market Perspective (2019-2030)
2.2 Hospital-acquired infections (HAIs) Control Growth Trends by Region
2.2.1 Global Hospital-acquired infections (HAIs) Control Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Hospital-acquired infections (HAIs) Control Historic Market Size by Region (2019-2024)
2.2.3 Hospital-acquired infections (HAIs) Control Forecasted Market Size by Region (2025-2030)
2.3 Hospital-acquired infections (HAIs) Control Market Dynamics
2.3.1 Hospital-acquired infections (HAIs) Control Industry Trends
2.3.2 Hospital-acquired infections (HAIs) Control Market Drivers
2.3.3 Hospital-acquired infections (HAIs) Control Market Challenges
2.3.4 Hospital-acquired infections (HAIs) Control Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Hospital-acquired infections (HAIs) Control Players by Revenue
3.1.1 Global Top Hospital-acquired infections (HAIs) Control Players by Revenue (2019-2024)
3.1.2 Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Players (2019-2024)
3.2 Global Hospital-acquired infections (HAIs) Control Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Hospital-acquired infections (HAIs) Control Revenue
3.4 Global Hospital-acquired infections (HAIs) Control Market Concentration Ratio
3.4.1 Global Hospital-acquired infections (HAIs) Control Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Hospital-acquired infections (HAIs) Control Revenue in 2023
3.5 Hospital-acquired infections (HAIs) Control Key Players Head office and Area Served
3.6 Key Players Hospital-acquired infections (HAIs) Control Product Solution and Service
3.7 Date of Enter into Hospital-acquired infections (HAIs) Control Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Hospital-acquired infections (HAIs) Control Breakdown Data by Type
4.1 Global Hospital-acquired infections (HAIs) Control Historic Market Size by Type (2019-2024)
4.2 Global Hospital-acquired infections (HAIs) Control Forecasted Market Size by Type (2025-2030)
5 Hospital-acquired infections (HAIs) Control Breakdown Data by Application
5.1 Global Hospital-acquired infections (HAIs) Control Historic Market Size by Application (2019-2024)
5.2 Global Hospital-acquired infections (HAIs) Control Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Hospital-acquired infections (HAIs) Control Market Size (2019-2030)
6.2 North America Hospital-acquired infections (HAIs) Control Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Hospital-acquired infections (HAIs) Control Market Size by Country (2019-2024)
6.4 North America Hospital-acquired infections (HAIs) Control Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Hospital-acquired infections (HAIs) Control Market Size (2019-2030)
7.2 Europe Hospital-acquired infections (HAIs) Control Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Hospital-acquired infections (HAIs) Control Market Size by Country (2019-2024)
7.4 Europe Hospital-acquired infections (HAIs) Control Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Hospital-acquired infections (HAIs) Control Market Size (2019-2030)
8.2 Asia-Pacific Hospital-acquired infections (HAIs) Control Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Hospital-acquired infections (HAIs) Control Market Size by Region (2019-2024)
8.4 Asia-Pacific Hospital-acquired infections (HAIs) Control Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Hospital-acquired infections (HAIs) Control Market Size (2019-2030)
9.2 Latin America Hospital-acquired infections (HAIs) Control Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Hospital-acquired infections (HAIs) Control Market Size by Country (2019-2024)
9.4 Latin America Hospital-acquired infections (HAIs) Control Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size (2019-2030)
10.2 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Country (2019-2024)
10.4 Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 STERIS Corporation
11.1.1 STERIS Corporation Company Detail
11.1.2 STERIS Corporation Business Overview
11.1.3 STERIS Corporation Hospital-acquired infections (HAIs) Control Introduction
11.1.4 STERIS Corporation Revenue in Hospital-acquired infections (HAIs) Control Business (2019-2024)
11.1.5 STERIS Corporation Recent Development
11.2 Advanced Sterilization Products Division
11.2.1 Advanced Sterilization Products Division Company Detail
11.2.2 Advanced Sterilization Products Division Business Overview
11.2.3 Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Introduction
11.2.4 Advanced Sterilization Products Division Revenue in Hospital-acquired infections (HAIs) Control Business (2019-2024)
11.2.5 Advanced Sterilization Products Division Recent Development
11.3 Hoffmann-La Roche
11.3.1 Hoffmann-La Roche Company Detail
11.3.2 Hoffmann-La Roche Business Overview
11.3.3 Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Introduction
11.3.4 Hoffmann-La Roche Revenue in Hospital-acquired infections (HAIs) Control Business (2019-2024)
11.3.5 Hoffmann-La Roche Recent Development
11.4 Pfizer
11.4.1 Pfizer Company Detail
11.4.2 Pfizer Business Overview
11.4.3 Pfizer Hospital-acquired infections (HAIs) Control Introduction
11.4.4 Pfizer Revenue in Hospital-acquired infections (HAIs) Control Business (2019-2024)
11.4.5 Pfizer Recent Development
11.5 Becton Dickinson
11.5.1 Becton Dickinson Company Detail
11.5.2 Becton Dickinson Business Overview
11.5.3 Becton Dickinson Hospital-acquired infections (HAIs) Control Introduction
11.5.4 Becton Dickinson Revenue in Hospital-acquired infections (HAIs) Control Business (2019-2024)
11.5.5 Becton Dickinson Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of TablesList of Tables
Table 1. Global Hospital-acquired infections (HAIs) Control Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
Table 2. Key Players of Diagnostic techniques
Table 3. Key Players of Dleaning and sterilization
Table 4. Key Players of Treatment
Table 5. Global Hospital-acquired infections (HAIs) Control Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
Table 6. Global Hospital-acquired infections (HAIs) Control Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
Table 7. Global Hospital-acquired infections (HAIs) Control Market Size by Region (2019-2024) & (US$ Million)
Table 8. Global Hospital-acquired infections (HAIs) Control Market Share by Region (2019-2024)
Table 9. Global Hospital-acquired infections (HAIs) Control Forecasted Market Size by Region (2025-2030) & (US$ Million)
Table 10. Global Hospital-acquired infections (HAIs) Control Market Share by Region (2025-2030)
Table 11. Hospital-acquired infections (HAIs) Control Market Trends
Table 12. Hospital-acquired infections (HAIs) Control Market Drivers
Table 13. Hospital-acquired infections (HAIs) Control Market Challenges
Table 14. Hospital-acquired infections (HAIs) Control Market Restraints
Table 15. Global Hospital-acquired infections (HAIs) Control Revenue by Players (2019-2024) & (US$ Million)
Table 16. Global Hospital-acquired infections (HAIs) Control Market Share by Players (2019-2024)
Table 17. Global Top Hospital-acquired infections (HAIs) Control Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-acquired infections (HAIs) Control as of 2023)
Table 18. Ranking of Global Top Hospital-acquired infections (HAIs) Control Companies by Revenue (US$ Million) in 2023
Table 19. Global 5 Largest Players Market Share by Hospital-acquired infections (HAIs) Control Revenue (CR5 and HHI) & (2019-2024)
Table 20. Key Players Headquarters and Area Served
Table 21. Key Players Hospital-acquired infections (HAIs) Control Product Solution and Service
Table 22. Date of Enter into Hospital-acquired infections (HAIs) Control Market
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Hospital-acquired infections (HAIs) Control Market Size by Type (2019-2024) & (US$ Million)
Table 25. Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Type (2019-2024)
Table 26. Global Hospital-acquired infections (HAIs) Control Forecasted Market Size by Type (2025-2030) & (US$ Million)
Table 27. Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Type (2025-2030)
Table 28. Global Hospital-acquired infections (HAIs) Control Market Size by Application (2019-2024) & (US$ Million)
Table 29. Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Application (2019-2024)
Table 30. Global Hospital-acquired infections (HAIs) Control Forecasted Market Size by Application (2025-2030) & (US$ Million)
Table 31. Global Hospital-acquired infections (HAIs) Control Revenue Market Share by Application (2025-2030)
Table 32. North America Hospital-acquired infections (HAIs) Control Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 33. North America Hospital-acquired infections (HAIs) Control Market Size by Country (2019-2024) & (US$ Million)
Table 34. North America Hospital-acquired infections (HAIs) Control Market Size by Country (2025-2030) & (US$ Million)
Table 35. Europe Hospital-acquired infections (HAIs) Control Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 36. Europe Hospital-acquired infections (HAIs) Control Market Size by Country (2019-2024) & (US$ Million)
Table 37. Europe Hospital-acquired infections (HAIs) Control Market Size by Country (2025-2030) & (US$ Million)
Table 38. Asia-Pacific Hospital-acquired infections (HAIs) Control Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
Table 39. Asia-Pacific Hospital-acquired infections (HAIs) Control Market Size by Region (2019-2024) & (US$ Million)
Table 40. Asia-Pacific Hospital-acquired infections (HAIs) Control Market Size by Region (2025-2030) & (US$ Million)
Table 41. Latin America Hospital-acquired infections (HAIs) Control Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 42. Latin America Hospital-acquired infections (HAIs) Control Market Size by Country (2019-2024) & (US$ Million)
Table 43. Latin America Hospital-acquired infections (HAIs) Control Market Size by Country (2025-2030) & (US$ Million)
Table 44. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
Table 45. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Country (2019-2024) & (US$ Million)
Table 46. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size by Country (2025-2030) & (US$ Million)
Table 47. STERIS Corporation Company Detail
Table 48. STERIS Corporation Business Overview
Table 49. STERIS Corporation Hospital-acquired infections (HAIs) Control Product
Table 50. STERIS Corporation Revenue in Hospital-acquired infections (HAIs) Control Business (2019-2024) & (US$ Million)
Table 51. STERIS Corporation Recent Development
Table 52. Advanced Sterilization Products Division Company Detail
Table 53. Advanced Sterilization Products Division Business Overview
Table 54. Advanced Sterilization Products Division Hospital-acquired infections (HAIs) Control Product
Table 55. Advanced Sterilization Products Division Revenue in Hospital-acquired infections (HAIs) Control Business (2019-2024) & (US$ Million)
Table 56. Advanced Sterilization Products Division Recent Development
Table 57. Hoffmann-La Roche Company Detail
Table 58. Hoffmann-La Roche Business Overview
Table 59. Hoffmann-La Roche Hospital-acquired infections (HAIs) Control Product
Table 60. Hoffmann-La Roche Revenue in Hospital-acquired infections (HAIs) Control Business (2019-2024) & (US$ Million)
Table 61. Hoffmann-La Roche Recent Development
Table 62. Pfizer Company Detail
Table 63. Pfizer Business Overview
Table 64. Pfizer Hospital-acquired infections (HAIs) Control Product
Table 65. Pfizer Revenue in Hospital-acquired infections (HAIs) Control Business (2019-2024) & (US$ Million)
Table 66. Pfizer Recent Development
Table 67. Becton Dickinson Company Detail
Table 68. Becton Dickinson Business Overview
Table 69. Becton Dickinson Hospital-acquired infections (HAIs) Control Product
Table 70. Becton Dickinson Revenue in Hospital-acquired infections (HAIs) Control Business (2019-2024) & (US$ Million)
Table 71. Becton Dickinson Recent Development
Table 72. Research Programs/Design for This Report
Table 73. Key Data Information from Secondary Sources
Table 74. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Hospital-acquired infections (HAIs) Control Market Size Comparison by Type (2024-2030) & (US$ Million)
Figure 2. Global Hospital-acquired infections (HAIs) Control Market Share by Type: 2023 VS 2030
Figure 3. Diagnostic techniques Features
Figure 4. Dleaning and sterilization Features
Figure 5. Treatment Features
Figure 6. Global Hospital-acquired infections (HAIs) Control Market Size Comparison by Application (2024-2030) & (US$ Million)
Figure 7. Global Hospital-acquired infections (HAIs) Control Market Share by Application: 2023 VS 2030
Figure 8. General Hospital Case Studies
Figure 9. Infectious Disease Hospital Case Studies
Figure 10. Hospital-acquired infections (HAIs) Control Report Years Considered
Figure 11. Global Hospital-acquired infections (HAIs) Control Market Size (US$ Million), Year-over-Year: 2019-2030
Figure 12. Global Hospital-acquired infections (HAIs) Control Market Size, (US$ Million), 2019 VS 2023 VS 2030
Figure 13. Global Hospital-acquired infections (HAIs) Control Market Share by Region: 2023 VS 2030
Figure 14. Global Hospital-acquired infections (HAIs) Control Market Share by Players in 2023
Figure 15. Global Top Hospital-acquired infections (HAIs) Control Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Hospital-acquired infections (HAIs) Control as of 2023)
Figure 16. The Top 10 and 5 Players Market Share by Hospital-acquired infections (HAIs) Control Revenue in 2023
Figure 17. North America Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 18. North America Hospital-acquired infections (HAIs) Control Market Share by Country (2019-2030)
Figure 19. United States Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 20. Canada Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 21. Europe Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 22. Europe Hospital-acquired infections (HAIs) Control Market Share by Country (2019-2030)
Figure 23. Germany Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 24. France Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 25. U.K. Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 26. Italy Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 27. Russia Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 28. Nordic Countries Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 29. Asia-Pacific Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 30. Asia-Pacific Hospital-acquired infections (HAIs) Control Market Share by Region (2019-2030)
Figure 31. China Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 32. Japan Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 33. South Korea Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 34. Southeast Asia Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 35. India Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 36. Australia Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 37. Latin America Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 38. Latin America Hospital-acquired infections (HAIs) Control Market Share by Country (2019-2030)
Figure 39. Mexico Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 40. Brazil Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 41. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 42. Middle East & Africa Hospital-acquired infections (HAIs) Control Market Share by Country (2019-2030)
Figure 43. Turkey Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 44. Saudi Arabia Hospital-acquired infections (HAIs) Control Market Size YoY Growth (2019-2030) & (US$ Million)
Figure 45. STERIS Corporation Revenue Growth Rate in Hospital-acquired infections (HAIs) Control Business (2019-2024)
Figure 46. Advanced Sterilization Products Division Revenue Growth Rate in Hospital-acquired infections (HAIs) Control Business (2019-2024)
Figure 47. Hoffmann-La Roche Revenue Growth Rate in Hospital-acquired infections (HAIs) Control Business (2019-2024)
Figure 48. Pfizer Revenue Growth Rate in Hospital-acquired infections (HAIs) Control Business (2019-2024)
Figure 49. Becton Dickinson Revenue Growth Rate in Hospital-acquired infections (HAIs) Control Business (2019-2024)
Figure 50. Bottom-up and Top-down Approaches for This Report
Figure 51. Data Triangulation
Figure 52. Key Executives Interviewed
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest IT & Electronics Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
